RCC New Drugs: Where Do They Fit? What Does the Future Hold?

被引:0
作者
Choueiri, Toni K. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Kidney Canc Ctr, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Med, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:28 / 31
页数:4
相关论文
共 12 条
  • [1] Combination therapy for metastatic renal cell carcinoma
    Buonerba, Carlo
    Di Lorenzo, Giuseppe
    Sonpavde, Guru
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (05)
  • [2] Chittoria N, RENAL CELL CARCINOMA
  • [3] Medical treatment of renal cancer: new horizons
    Greef, Basma
    Eisen, Tim
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (05) : 505 - 516
  • [4] Haas NB, 2016, NEW ENGL J MED, V387, P2008, DOI [10.1016/S0140-6736(16)00559-6.10, DOI 10.1016/S0140-6736(16)00559-6.10]
  • [5] Joseph RW, 2016, ONCOL TIMES, V38, P6, DOI [10.1097/01.COT.0000489528.40527.e7, DOI 10.1097/01.COT.0000489528.40527.E7]
  • [6] Ljungberg B, 2014, GUIDELINES RENAL CEL
  • [7] Phase III study of interferon Alfa-NL as adjuvant treatment for resectable renal cell carcinoma: An eastern cooperative oncology group/intergroup trial
    Messing, EM
    Manola, J
    Wilding, G
    Propert, K
    Fleischmann, J
    Crawford, ED
    Pontes, JE
    Hahn, R
    Trump, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1214 - 1222
  • [8] Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
    Motzer, R. J.
    Escudier, B.
    McDermott, D. F.
    George, S.
    Hammers, H. J.
    Srinivas, S.
    Tykodi, S. S.
    Sosman, J. A.
    Procopio, G.
    Plimack, E. R.
    Castellano, D.
    Choueiri, T. K.
    Gurney, H.
    Donskov, F.
    Bono, P.
    Wagstaff, J.
    Gauler, T. C.
    Ueda, T.
    Tomita, Y.
    Schutz, F. A.
    Kollmannsberger, C.
    Larkin, J.
    Ravaud, A.
    Simon, J. S.
    Xu, L-A
    Waxman, I. M.
    Sharma, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) : 1803 - 1813
  • [9] National Cancer Institute, SURV EP END RESEER
  • [10] Patel DN, 2016, CLIN ADV HEMATOL ONC, V14, P907